E-LIB Suche - Ergebnisse für: Teuber, G

1

Durability of HBsAg loss during or after antiviral treatmen..:

Teuber, G. ; Sprinzl, M. ; Hüppe, D....
Journal of Hepatology. 68 (2018) - p. S506 , 2018

Link: https://doi.org/10.1016/..

2

Addition of pegylated interferon alfa-2a to an ongoing nucl..:

Sprinzl, M. ; Grambihler, A. ; Teuber, G....
Journal of Hepatology. 68 (2018) - p. S108-S109 , 2018

Link: https://doi.org/10.1016/..

3

First real-world data on safety and effectiveness of glecap..:

Berg, T. ; Naumann, U. ; Stoehr, A....
Journal of Hepatology. 68 (2018) - p. S37 , 2018

Link: https://doi.org/10.1016/..

4

Real-world effectiveness and safety of Ombitasvir, Paritapr..:

Teuber, G. ; Buggisch, P. ; Naumann, U....
Journal of Hepatology. 66 (2017) 1 - p. S530 , 2017

Link: https://doi.org/10.1016/..

5

Effectiveness, safety and quality of life in patients treat..:

Buggisch, P. ; Naumann, U. ; Link, R....
Journal of Hepatology. 66 (2017) 1 - p. S530 , 2017

Link: https://doi.org/10.1016/..

6

Real‐world experience with the all‐oral, interferon‐free re..:

Welzel, T. M. ; Hinrichsen, H. ; Sarrazin, C....
Journal of Viral Hepatitis. 24 (2017) 10 - p. 840-849 , 2017

Link: https://doi.org/10.1111/..

7

Add on Interferon-Alpha-2a for the Treatment of HBeAg Negat..:

Sprinzl, M.F. ; Grambihler, A. ; Teuber, G....
Journal of Hepatology. 64 (2016) 2 - p. S221 , 2016

Link: https://doi.org/10.1016/..

8

Ledipasvir/Sofosbuvir Treatment for 8 Weeks in Treatment-Na..:

Buggisch, P. ; Böker, K.H.W. ; Günther, R....
Journal of Hepatology. 64 (2016) 2 - p. S810 , 2016

Link: https://doi.org/10.1016/..

9

P1137 TREATMENT OF CHRONIC HCV GENOTYPE 1 (G1) INFECTION WI..:

Buggisch, P. ; Löhr, H. ; Teuber, G....
Journal of Hepatology. 60 (2014) 1 - p. S461 , 2014

Link: https://doi.org/10.1016/..

10

P1149 PHYSICIAN ADHERENCE TO AND EFFICACY OF TRIPLE THERAPY..:

Mauss, S. ; Schober, A. ; John, C....
Journal of Hepatology. 60 (2014) 1 - p. S465-S466 , 2014

Link: https://doi.org/10.1016/..

11

P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC ..:

Christensen, S. ; Boeker, K.H.W. ; Eisenbach, C....
Journal of Hepatology. 60 (2014) 1 - p. S465 , 2014

Link: https://doi.org/10.1016/..

12

P1109 OVERTREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (C..:

Heidrich, B. ; Wiegand, S.B. ; Petersen, J....
Journal of Hepatology. 60 (2014) 1 - p. S447 , 2014

Link: https://doi.org/10.1016/..

13

P1147 OUTCOMES AND COSTS OF TREATING HEPATITIS C WITH PROTE..:

Stahmeyer, J.T. ; Rossol, S. ; Bert, F....
Journal of Hepatology. 60 (2014) 1 - p. S464-S465 , 2014

Link: https://doi.org/10.1016/..

14

P730 ADVERSE EVENTS AND CO-MEDICATION: A COMPARISON BETWEEN..:

Schott, E. ; Schober, A. ; Link, R....
Journal of Hepatology. 60 (2014) 1 - p. S313 , 2014

Link: https://doi.org/10.1016/..

15

912 LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE..:

Teuber, G. ; Mauss, S. ; Hüppe, D....
Journal of Hepatology. 58 (2013) - p. S376 , 2013

Link: https://doi.org/10.1016/..